Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
Persistence Market Research
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
Persistence Market Research
1
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
Persistence Market Research Released New Market Report on “Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020”.
Ataxia is a neurological condition, characterized by lack of voluntary coordination of muscle movement. Ataxia causes head trauma, stroke, Transient Ischemic Attack (TIA), tumor and toxic reaction. Progressive ataxia and weakness disorders are related to damage, degeneration or loss of neurons of the brain which leads to muscle coordination disability.
Browse the full “Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020” report at http://www.persistencemarketresearch.com/marketresearch/syndromes-progressive-ataxia-weakness-disorders-market.asp
The global market for treatments of syndromes of progressive ataxia and weakness disorders is categorized based on various drugs used for treatment of progressive ataxia syndromes, drugs for progressive weakness syndromes and by technology. The progressive ataxia syndrome segment is further sub-segmented into major diseases, such as Friedreich's ataxia, Gertsman-Straussler-Scheinker disease and Machado-Joseph disease. The progressive weakness syndrome segment includes amyotrophic lateral sclerosis, hereditary spastic paraplegia, hereditary neuropathies, progressive bulbar palsy and multiple sclerosis. The technology segment is further sub-segmented into small molecules based therapies and monoclonal antibody.
In terms of geography, the U.S. and Canada holds major market share of treatments for syndromes of progressive ataxia and weakness disorders market in North America. In Europe, Germany, France and the U.K are major markets for treatments of syndromes of progressive ataxia and weakness disorders. Globally, treatments for syndromes of progressive ataxia and weakness disorders market are growing due to novel drug development and rapid technological advancement for treatment of progressive ataxia and weakness disorders. Some of the major technological advancement involved in growth of the market are protein mis-folding, gene mutation and stem cell therapy. In addition, increased collaborations between industry players for development of new therapies is a key trend for the market. However, patent expiries of major drugs hampers growth of the treatments for syndromes of progressive ataxia and weakness disorders market. Moreover, stringent regulations and standard requires for approval process of new drugs impede growth of the treatments for syndromes of progressive ataxia and
Persistence Market Research
2
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020 weakness disorders market. Several government agencies, such as FDA and European Medicines Agency, are responsible for the approval of every drug. In addition, the approval process takes a very long time to approve a specific drug.
Some of the major companies operating in the treatment for syndromes of progressive ataxia and weakness disorders market are Abbott Laboratories, Acorda Therapeutics Inc., American Regent Inc., Baxter International Inc., Biogen Idec., Bristol-Myers Squibb, Cadila Healthcare Ltd., Eli Lilly and Company, Glaxosmilthkline Plc., Sanofi, Roche Holding Ltd., Pfizer Inc. and Novartis AG.
Request For Full Report With TOC Visit: http://www.persistencemarketresearch.com/samples/2834 Key points covered in the report:1. Report segments the market on the basis of types, application, products, technology, etc (as applicable) 2. The report covers geographic segmentation North America Europe Asia RoW 3. The report provides the market size and forecast for the different segments and geographies for the period of 2010 to 2020 4. The report provides company profiles of some of the leading companies operating in the market 5. The report also provides porters five forces analysis of the market.
Browse the full “All Upcoming Persistence Market's ” report at http://www.persistencemarketresearch.com/forthcoming-reports.asp
Persistence Market Research
3
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
About Us: Persistence Market Research is a global market research firm specializing- syndicated research, custom research, and consulting services At Persistence Market Research (PMR), we are in the business of accelerating your business. As a fullservice market research firm, we stand committed to bringing more accuracy and speed to your business decisions. From ready-to-purchase market research reports to customized global research solutions, our engagement models are highly flexible without compromising on our deep-seated research values. Briefly stated, our mission is to give you access to forecasts and trends analyses that put you on the path to profitability.
PMR’s Services Go Beyond Gleaning Data: Most enterprises believe that IT and databases are enough to make an accurate decision. While we do not dispute that, consider this: How long does it take to make an accurate and strategic million-dollar decision? We strive to deliver both even with demanding deadlines. Facilitating Rapid and Informed Business Decisions PMR was founded with one goal in mind: to offer enterprises a tangible business advantage by carefully balancing traditional and modern-day research methodologies. We are proud of our seasoned market research analysts and consultants that have a finger on the pulse of global markets. Team Persistence is all about facilitating change and enhancing profits. With the current global economic scenario, there are several imperatives to doing business. Compromising on quality doesn’t have to be one of them. We believe in disciplined research based on best practices consistent with your budget layout.
Persistence Market Research
4
Treatments for Syndromes of Progressive Ataxia and Weakness Disorders - Global Industry Analysis and Forecast to 2020
Contact Us: Addie Thomes 305 Broadway, 7th Floor, New York City, NY 10007, United States. Phone: +1-646-568-7751 USA/Canada Toll Free Number. 1-800-961-0353 E-mail: Sales@persistencemarketresearch.com Web : http://www.persistencemarketresearch.com/ Press Release : http://www.persistencemarketresearch.com/media-releases.asp Articles : http://www.persistencemarketresearch.com/articles.asp
Persistence Market Research
5